Chemoinformaics analysis of 3-O-METHYLELLAGIC ACID
| Molecular Weight | 316.221 | nRot | 1 |
| Heavy Atom Molecular Weight | 308.157 | nRig | 21 |
| Exact Molecular Weight | 316.022 | nRing | 4 |
| Solubility: LogS | -4.307 | nHRing | 2 |
| Solubility: LogP | 1.172 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 4 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 2 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 19 |
| nHA | 8 | APOL | 36.8003 |
| nHD | 3 | BPOL | 14.9697 |
| QED | 0.274 |
| Synth | 2.951 |
| Natural Product Likeliness | 1.495 |
| NR-PPAR-gamma | 0.854 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.031 |
| Pgp-sub | 0.03 |
| HIA | 0.4 |
| CACO-2 | -5.196 |
| MDCK | 0.0000185 |
| BBB | 0.014 |
| PPB | 0.812493 |
| VDSS | 0.763 |
| FU | 0.263846 |
| CYP1A2-inh | 0.923 |
| CYP1A2-sub | 0.781 |
| CYP2c19-inh | 0.022 |
| CYP2c19-sub | 0.058 |
| CYP2c9-inh | 0.468 |
| CYP2c9-sub | 0.741 |
| CYP2d6-inh | 0.025 |
| CYP2d6-sub | 0.162 |
| CYP3a4-inh | 0.13 |
| CYP3a4-sub | 0.03 |
| CL | 2.46 |
| T12 | 0.833 |
| hERG | 0.007 |
| Ames | 0.208 |
| ROA | 0.105 |
| SkinSen | 0.816 |
| Carcinogencity | 0.047 |
| EI | 0.866 |
| Respiratory | 0.072 |
| NR-Aromatase | 0.796 |
| Antiviral | Yes |
| Prediction | 0.658419 |